219 related articles for article (PubMed ID: 23296582)
1. Pregnancy and isotretinoin therapy.
Choi JS; Koren G; Nulman I
CMAJ; 2013 Mar; 185(5):411-3. PubMed ID: 23296582
[No Abstract] [Full Text] [Related]
2. Pregnancy and isotretinoin therapy.
Dumont T; Black A
CMAJ; 2013 Apr; 185(6):508. PubMed ID: 23550056
[No Abstract] [Full Text] [Related]
3. Pregnancy and isotretinoin therapy.
Choi JS; Koren G; Nulman I
CMAJ; 2013 Apr; 185(6):508. PubMed ID: 23550057
[No Abstract] [Full Text] [Related]
4. [Pregnancy after isotretinoin use].
Manders KC; de Vries LC; Roumen FJ
Ned Tijdschr Geneeskd; 2013; 157(41):A6567. PubMed ID: 24103139
[TBL] [Abstract][Full Text] [Related]
5. We Pledge to Change iPLEDGE.
Pierson JC; Ferris LK; Schwarz EB
JAMA Dermatol; 2015 Jul; 151(7):701-2. PubMed ID: 25853235
[No Abstract] [Full Text] [Related]
6. Isotretinoin prescribing: finding a balance between benefit and risk.
Stern RS
Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):611-3. PubMed ID: 16134100
[No Abstract] [Full Text] [Related]
7. Family physicians and accutane.
Van Durme DJ
Am Fam Physician; 2000 Oct; 62(8):1772, 1774, 1777. PubMed ID: 11057835
[No Abstract] [Full Text] [Related]
8. The power of Accutane. The benefits and risks of a breakthrough acne drug.
Meadows M
FDA Consum; 2001; 35(2):18-23. PubMed ID: 11444244
[No Abstract] [Full Text] [Related]
9. [30 years with isotretinoin. "Miracle medicine" against acne with many side effects].
Mobacken H; Sundström A; Vahlquist A
Lakartidningen; 2014 Jan 15-28; 111(3-4):93-6. PubMed ID: 24552013
[No Abstract] [Full Text] [Related]
10. Optimizing Isotretinoin Treatment of Acne: Update on Current Recommendations for Monitoring, Dosing, Safety, Adverse Effects, Compliance, and Outcomes.
Landis MN
Am J Clin Dermatol; 2020 Jun; 21(3):411-419. PubMed ID: 32107726
[TBL] [Abstract][Full Text] [Related]
11. How to ensure fetal safety when mothers use isotretinoin (Accutane).
Koren G; Pastuszak A
Can Fam Physician; 1997 Feb; 43():216-9. PubMed ID: 9040906
[No Abstract] [Full Text] [Related]
12. Compliance with pregnancy prevention programmes of isotretinoin in Europe: a systematic review.
Crijns HJ; Straus SM; Gispen-de Wied C; de Jong-van den Berg LT
Br J Dermatol; 2011 Feb; 164(2):238-44. PubMed ID: 20716214
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy, abortion and the dangers of prescribing vitamin A analogs in Australia.
Lipson T
Australas J Dermatol; 1996 May; 37(2):114-5. PubMed ID: 8687330
[No Abstract] [Full Text] [Related]
14. Isotretinoin, Patient Safety, and Patient-Centered Care-Time to Reform iPLEDGE.
Barbieri JS; Frieden IJ; Nagler AR
JAMA Dermatol; 2020 Jan; 156(1):21-22. PubMed ID: 31664426
[No Abstract] [Full Text] [Related]
15. Thalidomide and isotretinoin--why treat them differently?
Robert E
Reprod Toxicol; 1996; 10(1):1-2. PubMed ID: 8998379
[No Abstract] [Full Text] [Related]
16. Pregnancy and pregnancy rates in association with isotretinoin (Accutane).
Brinker A; Trontell A; Beitz J
J Am Acad Dermatol; 2002 Nov; 47(5):798-9. PubMed ID: 12399783
[No Abstract] [Full Text] [Related]
17. A comparative review of the isotretinoin pregnancy risk management programs across four continents.
Kovitwanichkanont T; Driscoll T
Int J Dermatol; 2018 Sep; 57(9):1035-1046. PubMed ID: 29508918
[TBL] [Abstract][Full Text] [Related]
18. [Never give negative pregnancy advice].
Oepkes D
Ned Tijdschr Geneeskd; 2013; 157(38):A6792. PubMed ID: 24330800
[TBL] [Abstract][Full Text] [Related]
19. Isotretinoin: update on controversial issues.
Prevost N; English JC
J Pediatr Adolesc Gynecol; 2013 Oct; 26(5):290-3. PubMed ID: 24147278
[TBL] [Abstract][Full Text] [Related]
20. FDA, Roche to implement new dispensing procedures for isotretinoin.
Young D
Am J Health Syst Pharm; 2001 Dec; 58(24):2359-60. PubMed ID: 11794946
[No Abstract] [Full Text] [Related]
[Next] [New Search]
